ND Committee Review
Internal Medical Policy Committee 1-22-2020 New Policy for North Dakota
Internal Medical Policy Committee 3-16-2020
- Added new code C9053, and
- Added additional diagnosis codes
Internal Medical Policy Committee 7-22-2020 - Effective July 01, 2020
- Removed C9053, and
- Added new code, J0791
Internal Medical Policy Committee 9-21-2020 Updated diagnosis codes
Internal Medical Policy Committee 11-19-2020 No clinical content change
Internal Medical Policy Committee 3-17-2021 Annual review, no clinical content change
Internal Medical Policy Committee 3-23-2022 Annual review no clinical content change
Internal Medical Policy Committee 9-28-2022
- Added reauthorization criteria, and
- Added note: "Crizanlizumab (Adakveo) is not to be used in combination with voxelotor (Oxbryta)."
- Updated experimental/investigational statement
Internal Medical Policy Committee 9-12-2023
- Annual review, no clinical content change